Maternal and neonatal outcome in early- and late-onset pre-eclampsia.

J Moodley, F Paruk

Journal: Seminars in neonatology : SN 2000;5(3):197-207

PMID: 10956445

Full Text on Elsevier Science View on PubMed

Abstract

Early-onset pre-eclampsia and late-onset pre-eclampsia, by virtue of their unpredictable nature and prediliction for multi-organ involvement, are associated with substantial maternal and fetal morbidity and mortality. Recent years have seen the introduction of the concepts of care in specialized units, expectant management of pre-eclampsia, conservative management of the HELLP syndrome (haemolysis, elevated liver enzymes, low platelets), usage of magnesium sulphate and improved feto-maternal surveillance. It is important to note that these factors also influence maternal and neonatal outcome.

Address: Department of Obstetrics and Gynaecology and MRC/UN Pregnancy Hypertension Research Unit, University of Natal Medical School, Durban, South Africa.

DOI: 10.1053/siny.2000.0023

Link outs

Free resources

Medical:

https://medlineplus.gov/bloodpressuremedicines.htm...

Subscription / membership required

Full Text Sources:

https://linkinghub.elsevier.com/retrieve/pii/S1084...

MeSH Terms: Antihypertensive Agents, Eclampsia, Female, HELLP Syndrome, Humans, Infant, Newborn, Infant, Newborn, Diseases, Magnesium Sulfate, Pre-Eclampsia, Pregnancy, Recurrence, Respiratory Distress Syndrome, Newborn, Risk Factors, Survival Analysis, Time Factors